StockDuty ← Dashboard Sep 03, 2026 06:13 AM ET
SignalFDA/Bio

TEZSPIRE’s Positive EoE Phase 3 Results Could Be A Game Changer For Amgen (AMGN)

Phase 3 EoE success signals major label expansion for Amgen.

Phase 3 EoE success signals major label expansion for Amgen.
Phase 3 EoE success signals major label expansion for Amgen. — impact context not separately stored; see What changed.
Sources